India's Marksans Pharma rises after Q1 profit boost
** Shares of Marksans Pharma MARK.NS up 9.4% at 205.4
rupees, its steepest gain since July 24
** Pharmaceutical formulations maker's Q1 consol net profit
grew ~30%, rev up 18%
** Shares see busiest day in about 3 weeks, with over 3.2
mln shares traded
** Stock up 28% YTD, vs an 81% and 9% rise in peers Natco
Pharma NATP.NS and Mankind Pharma MNKI.NS , respectively
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees